appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Syngene International Ltd
SYNGENE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Syngene International Limited is a contract research company. It is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies.
Investor PresentationView older
View Older PresentationsPeersCompare with peers
Divi's Laboratories Ltd
Aarti Pharmalabs Ltd
Dishman Carbogen Amcis Ltd
Vimta Labs Ltd
Brooks Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Syngene International Q4 Results: Profit Up 5.5% At Rs 188.6 Crore, Revenue Falls
1 day ago•Bloomberg Quint
Goldman Sachs Advises Shareholders To Sell And Buy Their Stakes In These Firms - News18
1 week ago•News18
Trade Spotlight | Your strategy to deal in Syngene International, IRCTC, CDSL today
1 week ago•Moneycontrol
Recent EventsAll events
Allotment of Securities
Syngene International Limited has informed the Exchange regarding allotment of Shares under Syngene Restricted Stock Unit Long Term Incentive Plan FY 2020 at its meeting held on April 24, 2024. | Download
Syngene International Limited has informed the Exchange regarding allotment of Shares under Syngene Restricted Stock Unit Long Term Incentive Plan FY 2020 at its meeting held on April 24, 2024. | Download
Cash Dividend
Special • Div/Share: ₹ 0.75
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant